Alnylam Pharmaceuticals reports a stock acquisition by director David E.I. Pyott, reflecting confidence in the company's future.
| Name | ALNYLAM PHARMACEUTICALS, INC. |
|---|---|
| CIK | 0001178670 |
| Tickers | ALNY |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 770602661 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | — |
| Phone | (617) 551-8200 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 1 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Alnylam Pharmaceuticals reports a stock acquisition by director David E.I. Pyott, reflecting confidence in the company's future.
FMR LLC has raised its ownership in Alnylam Pharmaceuticals to 9.5%, reflecting strong institutional interest in the biotech firm.
Alnylam Pharmaceuticals reveals the departure of its Chief Commercialization Officer and initiates a $1 billion stock buyback program.
Alnylam Pharmaceuticals shares strong Q3 results, indicating a robust financial position and advancements in its drug pipeline, impacting the pharmaceutical industry.
Alnylam Pharmaceuticals posts impressive Q3 results, highlighting significant revenue growth and advancements in its TTR franchise, signaling strong market position.
1692 filing rows loaded from submissions recent; extra archives: CIK0001178670-submissions-001.json (692 filings, 2002-07-09 to 2014-10-08).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | 4 | PRIMARY DOCUMENT | 0001178670-26-000091 | 5905 | ||||||
| 2026-11-16 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000726 | 005-79884 | 261556524 | 34 | 7725 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001422848-26-000134 | 005-79884 | 261553926 | 34 | 7704 | |||
| 2026-11-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001422849-26-000177 | 005-79884 | 261551049 | 34 | 7645 | |||
| 2026-11-12 | 4 | PRIMARY DOCUMENT | 0001178670-26-000089 | 7749 | ||||||
| 2026-11-12 | 4 | PRIMARY DOCUMENT | 0001178670-26-000087 | 5425 | ||||||
| 2026-11-12 | 4 | PRIMARY DOCUMENT | 0001178670-26-000085 | 4555 | ||||||
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002695 | 005-79884 | 261526096 | 34 | 11988 | |||
| 2026-11-05 | 8-K | 8-K | 5.02,8.01 | 0001178670-26-000080 | 001-36407 | 261524833 | 34 | 152484 | 1 | 1 |
| 2026-10-30 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100121-26-001039 | 005-79884 | 261506861 | 34 | 7463 | |||
| 2026-10-29 | 10-Q | 10-Q | 0001178670-26-000076 | 001-36407 | 261497680 | 34 | 11499905 | 1 | 1 | |
| 2026-10-29 | 8-K | 8-K | 2.02,9.01 | 0001178670-26-000074 | 001-36407 | 261497657 | 34 | 513495 | 1 | 1 |
| 2026-10-06 | 4 | PRIMARY DOCUMENT | 0001178670-26-000068 | 4973 | ||||||
| 2026-10-02 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-007216 | 001-36407 | 261436046 | 33 | 4633 | |||
| 2026-09-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000065 | 6110 | ||||||
| 2026-07-30 | 10-Q | 10-Q | 0001178670-26-000062 | 001-36407 | 261220304 | 34 | 11125755 | 1 | 1 | |
| 2026-07-30 | 8-K | 8-K | 2.02,9.01 | 0001178670-26-000060 | 001-36407 | 261220294 | 34 | 515639 | 1 | 1 |
| 2026-06-03 | 4 | PRIMARY DOCUMENT | 0001178670-26-000048 | 17011 | ||||||
| 2026-06-03 | 4 | PRIMARY DOCUMENT | 0001178670-26-000047 | 5418 | ||||||
| 2026-06-03 | 3 | PRIMARY DOCUMENT | 0001178670-26-000046 | 7186 | ||||||
| 2026-06-01 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000618 | 001-36407 | 261051253 | 33 | 4565 | |||
| 2026-05-27 | 8-K | 8-K | 5.02,5.07 | 0001628280-26-038499 | 001-36407 | 261026646 | 34 | 166775 | 1 | 1 |
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000042 | 8495 | ||||||
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000041 | 7630 | ||||||
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000040 | 7622 | ||||||
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000039 | 8502 | ||||||
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000038 | 7676 | ||||||
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000037 | 7616 | ||||||
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000036 | 7630 | ||||||
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000035 | 8496 | ||||||
| 2026-05-22 | 4 | PRIMARY DOCUMENT | 0001178670-26-000034 | 7628 | ||||||
| 2026-05-14 | 4 | PRIMARY DOCUMENT | 0001178670-26-000017 | 6879 | ||||||
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001422849-26-000061 | 005-79884 | 26977678 | 34 | 7657 | |||
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001422848-26-000050 | 005-79884 | 26976424 | 34 | 7679 | |||
| 2026-05-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001107 | 005-79884 | 26946559 | 34 | 11610 | |||
| 2026-04-30 | 10-Q | 10-Q | 0001628280-26-028605 | 001-36407 | 26920246 | 34 | 8966268 | 1 | 1 | |
| 2026-04-30 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-028601 | 001-36407 | 26920191 | 34 | 479344 | 1 | 1 |
| 2026-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-000160 | 005-79884 | 26917224 | 34 | 7496 | |||
| 2026-04-07 | 4 | PRIMARY DOCUMENT | 0001178670-26-000014 | 29618 | ||||||
| 2026-04-07 | 3 | PRIMARY DOCUMENT | 0001178670-26-000012 | 9915 | ||||||
| 2026-04-06 | ARS | ARS | 0001140361-26-013365 | 001-36407 | 26841993 | 34 | 39247914 | |||
| 2026-04-06 | DEFA14A | DEFA14A | 0001628280-26-023924 | 001-36407 | 26841658 | 34 | 866239 | |||
| 2026-04-06 | DEF 14A | DEF 14A | 0001628280-26-023923 | 001-36407 | 26841639 | 34 | 33822931 | 1 | 1 | |
| 2026-04-06 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000425 | 001-36407 | 26841183 | 33 | 4559 | |||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000562 | 005-79884 | 26797551 | 34 | 7260 | |||
| 2026-03-06 | 4 | PRIMARY DOCUMENT | 0001735276-26-000063 | 27590 | ||||||
| 2026-03-06 | 4 | PRIMARY DOCUMENT | 0001735276-26-000062 | 19066 | ||||||
| 2026-03-06 | 4 | PRIMARY DOCUMENT | 0001735276-26-000061 | 19070 | ||||||
| 2026-03-06 | 4 | PRIMARY DOCUMENT | 0001735276-26-000060 | 18123 | ||||||
| 2026-03-06 | 4 | PRIMARY DOCUMENT | 0001735276-26-000059 | 26528 | ||||||
| 2026-03-05 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000296 | 001-36407 | 26726048 | 33 | 6513 | |||
| 2026-03-05 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000295 | 001-36407 | 26726029 | 33 | 5834 | |||
| 2026-03-04 | 4 | PRIMARY DOCUMENT | 0001735276-26-000053 | 27009 | ||||||
| 2026-03-04 | 4 | PRIMARY DOCUMENT | 0001735276-26-000052 | 35526 | ||||||
| 2026-03-04 | 4 | PRIMARY DOCUMENT | 0001735276-26-000051 | 34469 | ||||||
| 2026-03-04 | 4 | PRIMARY DOCUMENT | 0001735276-26-000050 | 26059 | ||||||
| 2026-03-04 | 4 | PRIMARY DOCUMENT | 0001735276-26-000049 | 7583 | ||||||
| 2026-03-04 | 4 | PRIMARY DOCUMENT | 0001735276-26-000048 | 29980 | ||||||
| 2026-03-04 | 8-K | 8-K | 5.02 | 0001628280-26-014728 | 001-36407 | 26722777 | 34 | 156944 | 1 | 1 |
| 2026-03-03 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000276 | 001-36407 | 26715665 | 33 | 6368 | |||
| 2026-03-03 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000273 | 001-36407 | 26714173 | 33 | 5692 | |||
| 2026-03-02 | 4 | PRIMARY DOCUMENT | 0001735276-26-000041 | 8419 | ||||||
| 2026-03-02 | 4 | PRIMARY DOCUMENT | 0001735276-26-000040 | 8422 | ||||||
| 2026-03-02 | 4 | PRIMARY DOCUMENT | 0001735276-26-000039 | 7477 | ||||||
| 2026-03-02 | 4 | PRIMARY DOCUMENT | 0001735276-26-000038 | 18332 | ||||||
| 2026-02-27 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000253 | 001-36407 | 26699565 | 33 | 5046 | |||
| 2026-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-26-000032 | 6104 | ||||||
| 2026-02-17 | 4 | PRIMARY DOCUMENT | 0001735276-26-000029 | 9358 | ||||||
| 2026-02-17 | 4 | PRIMARY DOCUMENT | 0001735276-26-000028 | 8293 | ||||||
| 2026-02-17 | 4 | PRIMARY DOCUMENT | 0001735276-26-000027 | 7351 | ||||||
| 2026-02-17 | 4 | PRIMARY DOCUMENT | 0001735276-26-000026 | 10290 | ||||||
| 2026-02-17 | 4 | PRIMARY DOCUMENT | 0001735276-26-000025 | 8296 | ||||||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000186 | 001-36407 | 26641229 | 33 | 5865 | |||
| 2026-02-12 | S-8 | S-8 | 0001628280-26-007687 | 333-293419 | 26626421 | 33 | 243155 | 1 | 1 | |
| 2026-02-12 | 10-K | 10-K | 0001628280-26-007497 | 001-36407 | 26623520 | 34 | 17731961 | 1 | 1 | |
| 2026-02-12 | 8-K | 8-K | 2.02,9.01 | 0001628280-26-007491 | 001-36407 | 26623503 | 34 | 601998 | 1 | 1 |
| 2026-01-14 | 4 | PRIMARY DOCUMENT | 0001735276-26-000015 | 44940 | ||||||
| 2026-01-14 | 4 | PRIMARY DOCUMENT | 0001735276-26-000014 | 43890 | ||||||
| 2026-01-14 | 4 | PRIMARY DOCUMENT | 0001735276-26-000013 | 43881 | ||||||
| 2026-01-14 | 4 | PRIMARY DOCUMENT | 0001735276-26-000012 | 42929 | ||||||
| 2026-01-14 | 4 | PRIMARY DOCUMENT | 0001735276-26-000011 | 54990 | ||||||
| 2026-01-13 | 144 | xsl144X01/primary_doc.xml | 0001969223-26-000038 | 001-36407 | 26530465 | 33 | 5213 | |||
| 2026-01-12 | 8-K | 8-K | 2.02 | 0001628280-26-001755 | 001-36407 | 26524668 | 34 | 235347 | 1 | 1 |
| 2026-01-07 | 4 | PRIMARY DOCUMENT | 0001735276-26-000005 | 5378 | ||||||
| 2026-01-07 | 3 | PRIMARY DOCUMENT | 0001735276-26-000004 | 7244 | ||||||
| 2025-12-11 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-315047 | 001-36407 | 251563514 | 34 | 166024 | 1 | 1 |
| 2025-12-03 | 8-K | 8-K | 5.02 | 0001628280-25-055084 | 001-36407 | 251547099 | 34 | 184367 | 1 | 1 |
| 2025-12-01 | 4 | PRIMARY DOCUMENT | 0001735276-25-000125 | 19540 | ||||||
| 2025-11-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000123 | 27181 | ||||||
| 2025-11-17 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000959 | 001-36407 | 251491051 | 33 | 5603 | |||
| 2025-11-14 | 4 | PRIMARY DOCUMENT | 0001735276-25-000120 | 50794 | ||||||
| 2025-11-12 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000940 | 001-36407 | 251472513 | 33 | 4645 | |||
| 2025-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002664 | 005-79884 | 251452546 | 34 | 11903 | |||
| 2025-10-30 | 10-Q | 10-Q | 0001628280-25-047345 | 001-36407 | 251432350 | 34 | 10085918 | 1 | 1 | |
| 2025-10-30 | 8-K | 8-K | 2.02,9.01 | 0001628280-25-047342 | 001-36407 | 251432320 | 34 | 521316 | 1 | 1 |
| 2025-10-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000118 | 5134 | ||||||
| 2025-10-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000117 | 29609 | ||||||
| 2025-10-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000116 | 29611 | ||||||
| 2025-10-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000115 | 26664 | ||||||
| 2025-10-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000114 | 29620 | ||||||
| 2025-10-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000113 | 39954 | ||||||
| 2025-10-03 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-25-230201 | 001-36407 | 251374038 | 34 | 1476038 | 1 | 1 |
| 2025-10-03 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000830 | 001-36407 | 251373836 | 33 | 5187 | |||
| 2025-09-22 | 3 | PRIMARY DOCUMENT | 0001735276-25-000105 | 7277 | ||||||
| 2025-09-12 | 8-K | 8-K | 1.01,2.03,3.02,8.01,9.01 | 0001193125-25-202366 | 001-36407 | 251312409 | 34 | 1284021 | 1 | 1 |
| 2025-09-11 | 4 | PRIMARY DOCUMENT | 0001735276-25-000097 | 35683 | ||||||
| 2025-09-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-199686 | 001-36407 | 251304670 | 34 | 193889 | 1 | 1 |
| 2025-09-09 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000750 | 001-36407 | 251303207 | 33 | 4575 | |||
| 2025-09-02 | 4 | PRIMARY DOCUMENT | 0001735276-25-000094 | 14344 | ||||||
| 2025-08-29 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000686 | 001-36407 | 251280788 | 33 | 5053 | |||
| 2025-08-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000092 | 32896 | ||||||
| 2025-08-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000091 | 20178 | ||||||
| 2025-08-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000090 | 21126 | ||||||
| 2025-08-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000089 | 21128 | ||||||
| 2025-08-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000088 | 21137 | ||||||
| 2025-08-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000087 | 9279 | ||||||
| 2025-08-19 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000634 | 001-36407 | 251231695 | 33 | 4538 | |||
| 2025-08-18 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000627 | 001-36407 | 251227989 | 33 | 4575 | |||
| 2025-08-15 | 4 | PRIMARY DOCUMENT | 0001735276-25-000079 | 45821 | ||||||
| 2025-08-14 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000610 | 001-36407 | 251219446 | 33 | 4579 | |||
| 2025-07-31 | 10-Q | 10-Q | 0001178670-25-000090 | 001-36407 | 251169534 | 34 | 8824525 | 1 | 1 | |
| 2025-07-31 | 8-K | 8-K | 2.02,9.01 | 0001178670-25-000089 | 001-36407 | 251169517 | 34 | 500400 | 1 | 1 |
| 2025-07-02 | 4 | PRIMARY DOCUMENT | 0001735276-25-000077 | 6108 | ||||||
| 2025-06-18 | 8-K | 8-K | 5.02 | 0001178670-25-000076 | 001-36407 | 251057552 | 34 | 175673 | 1 | 1 |
| 2025-06-17 | UPLOAD | filename1.pdf | 0000000000-25-006335 | 001-36407 | 39817 | |||||
| 2025-06-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000075 | 22673 | ||||||
| 2025-06-02 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000378 | 001-36407 | 251015009 | 33 | 5300 | |||
| 2025-05-30 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000372 | 001-36407 | 251011219 | 33 | 4644 | |||
| 2025-05-30 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000370 | 001-36407 | 251010994 | 33 | 4720 | |||
| 2025-05-22 | CORRESP | filename1.htm | 0001178670-25-000069 | 567027 | ||||||
| 2025-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000072 | 33444 | ||||||
| 2025-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-25-000071 | 5877 | ||||||
| 2025-05-15 | 144 | xsl144X01/primary_doc.xml | 0001969223-25-000313 | 001-36407 | 25952519 | 33 | 4527 | |||
| 2025-05-13 | 8-K | 8-K | 5.03,5.07 | 0001178670-25-000062 | 001-36407 | 25941144 | 34 | 195397 | 1 | 1 |
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000068 | 8445 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000067 | 8412 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000066 | 7577 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000065 | 7557 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000064 | 7631 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000063 | 8423 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000062 | 11637 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000061 | 7566 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000060 | 8391 | ||||||
| 2025-05-12 | 4 | PRIMARY DOCUMENT | 0001735276-25-000059 | 7520 | ||||||
| 2025-05-09 | UPLOAD | filename1.pdf | 0000000000-25-004975 | 001-36407 | 44732 | |||||
| 2025-05-06 | 4 | PRIMARY DOCUMENT | 0001735276-25-000047 | 5878 | ||||||
| 2025-05-01 | 10-Q | 10-Q | 0001178670-25-000052 | 001-36407 | 25899598 | 34 | 8033827 | 1 | 1 | |
| 2025-05-01 | 8-K | 8-K | 9.01 | 0001178670-25-000050 | 001-36407 | 25899546 | 34 | 462902 | 1 | 1 |
| 2025-04-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000378 | 005-79884 | 25816981 | 34 | 6306 | |||
| 2025-04-04 | DEFA14A | DEFA14A | 0001178670-25-000044 | 001-36407 | 25815168 | 34 | 41326 | |||
| 2025-03-25 | 4 | PRIMARY DOCUMENT | 0001735276-25-000041 | 11873 | ||||||
| 2025-03-25 | 4 | PRIMARY DOCUMENT | 0001735276-25-000040 | 9341 | ||||||
| 2025-03-24 | ARS | ARS | 0001193125-25-061427 | 001-36407 | 25764961 | 34 | 58724176 | |||
| 2025-03-24 | DEFA14A | DEFA14A | 0001193125-25-061424 | 001-36407 | 25764934 | 34 | 1054123 | |||
| 2025-03-24 | DEF 14A | DEF 14A | 0001178670-25-000040 | 001-36407 | 25764682 | 34 | 29376929 | 1 | 1 | |
| 2025-03-24 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000167 | 001-36407 | 25764318 | 33 | 4547 | |||
| 2025-03-24 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000163 | 001-36407 | 25764187 | 33 | 7840 | |||
| 2025-03-21 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000162 | 001-36407 | 25760412 | 33 | 7678 | |||
| 2025-03-21 | 8-K | 8-K | 8.01 | 0001178670-25-000038 | 001-36407 | 25758030 | 34 | 224665 | 1 | 1 |
| 2025-03-14 | 4 | PRIMARY DOCUMENT | 0001735276-25-000037 | 6960 | ||||||
| 2025-03-14 | PRE 14A | PRE 14A | 0001178670-25-000035 | 001-36407 | 25740207 | 34 | 29413407 | 1 | 1 | |
| 2025-03-05 | 8-K | 8-K | 5.02 | 0001178670-25-000031 | 001-36407 | 25711747 | 34 | 177215 | 1 | 1 |
| 2025-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-25-000035 | 7610 | ||||||
| 2025-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-25-000034 | 33702 | ||||||
| 2025-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-25-000033 | 19217 | ||||||
| 2025-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-25-000032 | 35594 | ||||||
| 2025-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-25-000031 | 21522 | ||||||
| 2025-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-25-000030 | 21566 | ||||||
| 2025-03-04 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000126 | 001-36407 | 25704318 | 33 | 5762 | |||
| 2025-03-04 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000125 | 001-36407 | 25704290 | 33 | 7188 | |||
| 2025-03-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000023 | 23151 | ||||||
| 2025-03-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000022 | 23109 | ||||||
| 2025-03-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000021 | 22204 | ||||||
| 2025-03-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000020 | 24258 | ||||||
| 2025-03-03 | 4 | PRIMARY DOCUMENT | 0001735276-25-000019 | 19193 | ||||||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000120 | 001-36407 | 25697957 | 33 | 6540 | |||
| 2025-03-03 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000119 | 001-36407 | 25697937 | 33 | 5169 | |||
| 2025-02-18 | 4 | PRIMARY DOCUMENT | 0001735276-25-000012 | 27638 | ||||||
| 2025-02-18 | 4 | PRIMARY DOCUMENT | 0001735276-25-000011 | 27603 | ||||||
| 2025-02-18 | 4 | PRIMARY DOCUMENT | 0001735276-25-000010 | 35668 | ||||||
| 2025-02-18 | 4 | PRIMARY DOCUMENT | 0001735276-25-000009 | 39012 | ||||||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000098 | 001-36407 | 25635046 | 33 | 5882 | |||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000097 | 001-36407 | 25635019 | 33 | 5169 | |||
| 2025-02-13 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001422848-25-000022 | 005-79884 | 25619279 | 34 | 7416 | |||
| 2025-02-13 | 10-K | 10-K | 0001178670-25-000026 | 001-36407 | 25617356 | 34 | 14466651 | 1 | 1 | |
| 2025-02-13 | 8-K | 8-K | 9.01 | 0001178670-25-000020 | 001-36407 | 25617293 | 34 | 541777 | 1 | 1 |
| 2025-01-29 | 4 | PRIMARY DOCUMENT | 0001735276-25-000004 | 14273 | ||||||
| 2025-01-27 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000045 | 001-36407 | 25558813 | 33 | 6804 | |||
| 2025-01-24 | 4 | PRIMARY DOCUMENT | 0001735276-25-000002 | 9715 | ||||||
| 2025-01-23 | 144 | xsl144X01/primary_doc.xml | 0001973141-25-000035 | 001-36407 | 25550352 | 33 | 4726 | |||
| 2025-01-13 | 8-K | 8-K | 2.02 | 0001178670-25-000008 | 001-36407 | 25524813 | 34 | 212948 | 1 | 1 |
| 2024-12-13 | 4 | PRIMARY DOCUMENT | 0001735276-24-000110 | 16963 | ||||||
| 2024-12-12 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000609 | 001-36407 | 241544842 | 33 | 4587 | |||
| 2024-11-27 | 4 | PRIMARY DOCUMENT | 0001735276-24-000108 | 15866 | ||||||
| 2024-11-27 | 4 | PRIMARY DOCUMENT | 0001735276-24-000107 | 16974 | ||||||
| 2024-11-27 | 4 | PRIMARY DOCUMENT | 0001735276-24-000106 | 15827 | ||||||
| 2024-11-27 | 4 | PRIMARY DOCUMENT | 0001735276-24-000105 | 14926 | ||||||
| 2024-11-27 | 4 | PRIMARY DOCUMENT | 0001735276-24-000104 | 22912 | ||||||
| 2024-11-27 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000581 | 001-36407 | 241511071 | 33 | 4575 | |||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002658 | 005-79884 | 241444427 | 34 | 8490 | |||
| 2024-11-08 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000383 | 005-79884 | 241438506 | 34 | 32199 | |||
| 2024-10-31 | 10-Q | 10-Q | 0001178670-24-000053 | 001-36407 | 241412575 | 34 | 9607084 | 1 | 1 | |
| 2024-10-31 | 8-K | 8-K | 9.01 | 0001178670-24-000052 | 001-36407 | 241412544 | 34 | 483797 | 1 | 1 |
| 2024-10-10 | 4 | PRIMARY DOCUMENT | 0001735276-24-000098 | 7200 | ||||||
| 2024-10-03 | 4 | PRIMARY DOCUMENT | 0001735276-24-000096 | 5172 | ||||||
| 2024-10-03 | 3 | PRIMARY DOCUMENT | 0001735276-24-000095 | 7328 | ||||||
| 2024-09-25 | UPLOAD | filename1.pdf | 0000000000-24-010900 | 001-36407 | 39895 | |||||
| 2024-08-22 | 4 | PRIMARY DOCUMENT | 0001735276-24-000085 | 9397 | ||||||
| 2024-08-22 | CORRESP | filename1.htm | 0001178670-24-000048 | 454842 | ||||||
| 2024-08-20 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000418 | 001-36407 | 241226150 | 33 | 5895 | |||
| 2024-08-14 | 4 | PRIMARY DOCUMENT | 0001735276-24-000083 | 22092 | ||||||
| 2024-08-12 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000409 | 001-36407 | 241196795 | 33 | 5109 | |||
| 2024-08-12 | SC 13G/A | filing.txt | 0000315066-24-001883 | 005-79884 | 241195245 | 34 | 8286 | |||
| 2024-08-12 | UPLOAD | filename1.pdf | 0000000000-24-009192 | 001-36407 | 44170 | |||||
| 2024-08-08 | 4 | PRIMARY DOCUMENT | 0001735276-24-000080 | 24265 | ||||||
| 2024-08-06 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000397 | 001-36407 | 241179213 | 33 | 4586 | |||
| 2024-08-02 | 4 | PRIMARY DOCUMENT | 0001735276-24-000077 | 9374 | ||||||
| 2024-08-01 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000378 | 001-36407 | 241166430 | 33 | 5242 | |||
| 2024-08-01 | 10-Q | 10-Q | 0001178670-24-000041 | 001-36407 | 241164509 | 34 | 10753164 | 1 | 1 | |
| 2024-08-01 | 8-K | 8-K | 9.01 | 0001178670-24-000039 | 001-36407 | 241164472 | 34 | 486691 | 1 | 1 |
| 2024-07-12 | 4 | PRIMARY DOCUMENT | 0001735276-24-000075 | 5788 | ||||||
| 2024-07-11 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000348 | 001-36407 | 241112467 | 33 | 4594 | |||
| 2024-07-05 | SC 13G/A | alnylam28062024.txt | 0001088875-24-000081 | 005-79884 | 241101862 | 34 | 10950 | |||
| 2024-06-27 | 4 | PRIMARY DOCUMENT | 0001735276-24-000072 | 8437 | ||||||
| 2024-06-26 | 4 | PRIMARY DOCUMENT | 0001735276-24-000070 | 19253 | ||||||
| 2024-06-26 | 4 | PRIMARY DOCUMENT | 0001735276-24-000069 | 29632 | ||||||
| 2024-06-26 | 4 | PRIMARY DOCUMENT | 0001735276-24-000068 | 28524 | ||||||
| 2024-06-26 | 4 | PRIMARY DOCUMENT | 0001735276-24-000067 | 28482 | ||||||
| 2024-06-26 | 4 | PRIMARY DOCUMENT | 0001735276-24-000066 | 27579 | ||||||
| 2024-06-26 | 4 | PRIMARY DOCUMENT | 0001735276-24-000065 | 28540 | ||||||
| 2024-06-25 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000323 | 001-36407 | 241069075 | 33 | 5234 | |||
| 2024-06-24 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000319 | 001-36407 | 241064211 | 33 | 4557 | |||
| 2024-05-31 | 4 | PRIMARY DOCUMENT | 0001735276-24-000058 | 12162 | ||||||
| 2024-05-29 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000274 | 001-36407 | 24998231 | 33 | 4585 | |||
| 2024-05-20 | 8-K | 8-K | 5.07 | 0001178670-24-000027 | 001-36407 | 24965127 | 34 | 172977 | 1 | 1 |
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000055 | 9709 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000054 | 9802 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000053 | 9712 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000052 | 9711 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000051 | 9758 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000050 | 9734 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000049 | 9691 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000048 | 9688 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000047 | 9728 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000046 | 9750 | ||||||
| 2024-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000045 | 9874 | ||||||
| 2024-05-02 | 10-Q | 10-Q | 0001178670-24-000023 | 001-36407 | 24905466 | 34 | 9295002 | 1 | 1 | |
| 2024-05-02 | 8-K | 8-K | 9.01 | 0001178670-24-000021 | 001-36407 | 24905453 | 34 | 441287 | 1 | 1 |
| 2024-04-01 | ARS | ARS | 0001193125-24-083479 | 001-36407 | 24810075 | 34 | 3489943 | |||
| 2024-04-01 | DEFA14A | DEFA14A | 0001193125-24-083471 | 001-36407 | 24810011 | 34 | 935429 | |||
| 2024-04-01 | DEF 14A | DEF 14A | 0001193125-24-083454 | 001-36407 | 24809904 | 34 | 4927349 | 1 | 1 | |
| 2024-03-28 | 3 | PRIMARY DOCUMENT | 0001735276-24-000033 | 14690 | ||||||
| 2024-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-24-000030 | 7950 | ||||||
| 2024-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-24-000029 | 9999 | ||||||
| 2024-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-24-000028 | 8856 | ||||||
| 2024-03-05 | 4 | PRIMARY DOCUMENT | 0001735276-24-000027 | 8894 | ||||||
| 2024-03-04 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-057906 | 001-36407 | 24715361 | 34 | 223297 | 1 | 1 |
| 2024-03-01 | 4 | PRIMARY DOCUMENT | 0001735276-24-000022 | 19073 | ||||||
| 2024-02-29 | 4 | PRIMARY DOCUMENT | 0001735276-24-000020 | 16204 | ||||||
| 2024-02-29 | 4 | PRIMARY DOCUMENT | 0001735276-24-000019 | 17111 | ||||||
| 2024-02-29 | 4 | PRIMARY DOCUMENT | 0001735276-24-000018 | 17149 | ||||||
| 2024-02-29 | 4 | PRIMARY DOCUMENT | 0001735276-24-000017 | 18252 | ||||||
| 2024-02-29 | 4 | PRIMARY DOCUMENT | 0001735276-24-000016 | 16454 | ||||||
| 2024-02-29 | 144 | xsl144X01/primary_doc.xml | 0001973141-24-000138 | 001-36407 | 24703405 | 33 | 4726 | |||
| 2024-02-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000010 | 13105 | ||||||
| 2024-02-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000009 | 11962 | ||||||
| 2024-02-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000008 | 11057 | ||||||
| 2024-02-20 | 4 | PRIMARY DOCUMENT | 0001735276-24-000007 | 12000 | ||||||
| 2024-02-15 | 10-K | 10-K | 0001178670-24-000008 | 001-36407 | 24644159 | 34 | 13966369 | 1 | 1 | |
| 2024-02-15 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 2.02,9.01 | 0001157523-24-000253 | 001-36407 | 24642207 | 34 | 783990 | 1 | 1 |
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020232 | 005-79884 | 24627499 | 34 | 13213 | |||
| 2024-02-09 | SC 13G/A | SEC SCHEDULE 13G | 0001422848-24-000213 | 005-79884 | 24616704 | 34 | 18461 | |||
| 2024-02-09 | SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000264 | 005-79884 | 24611424 | 34 | 38189 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001006 | 005-79884 | 24611380 | 34 | 8487 | |||
| 2024-02-05 | 4 | PRIMARY DOCUMENT | 0001735276-24-000002 | 13001 | ||||||
| 2024-01-29 | SC 13G/A | alnylam29122023.txt | 0001088875-24-000047 | 005-79884 | 24571888 | 34 | 11385 | |||
| 2024-01-26 | SC 13G/A | us02043q1076_012624.txt | 0001086364-24-004819 | 005-79884 | 24569160 | 34 | 13998 | |||
| 2024-01-19 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-011278 | 001-36407 | 24546012 | 34 | 145803 | 1 | 1 |
| 2024-01-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-24-003854 | 001-36407 | 24518273 | 34 | 180022 | 1 | 1 |
| 2023-12-29 | 4 | PRIMARY DOCUMENT | 0001735276-23-000081 | 9207 | ||||||
| 2023-12-27 | 144 | xsl144X01/primary_doc.xml | 0001973141-23-000369 | 001-36407 | 231517972 | 33 | 4544 | |||
| 2023-12-11 | 144 | xsl144X01/primary_doc.xml | 0001973141-23-000333 | 001-36407 | 231478189 | 33 | 4453 | |||
| 2023-11-02 | 10-Q | 10-Q | 0001178670-23-000023 | 001-36407 | 231370227 | 34 | 10534380 | 1 | 1 | |
| 2023-11-02 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 2.02,9.01 | 0001157523-23-001622 | 001-36407 | 231370194 | 34 | 693207 | 1 | 1 |
| 2023-10-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-253084 | 001-36407 | 231315650 | 34 | 190461 | 1 | 1 |
| 2023-09-28 | 8-K | 8-K | 5.02 | 0001193125-23-245768 | 001-36407 | 231290651 | 34 | 144905 | 1 | 1 |
| 2023-08-07 | 4 | PRIMARY DOCUMENT | 0001735276-23-000079 | 26207 | ||||||
| 2023-08-07 | 4 | PRIMARY DOCUMENT | 0001735276-23-000078 | 19443 | ||||||
| 2023-08-07 | 4 | PRIMARY DOCUMENT | 0001735276-23-000077 | 19480 | ||||||
| 2023-08-07 | 4 | PRIMARY DOCUMENT | 0001735276-23-000076 | 19721 | ||||||
| 2023-08-07 | 144 | xsl144X01/primary_doc.xml | 0001973141-23-000172 | 001-36407 | 231147685 | 33 | 4504 | |||
| 2023-08-04 | 4 | PRIMARY DOCUMENT | 0001735276-23-000071 | 21047 | ||||||
| 2023-08-03 | 10-Q | 10-Q | 0001178670-23-000015 | 001-36407 | 231138217 | 34 | 8222344 | 1 | 1 | |
| 2023-08-03 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-23-202313 | 001-36407 | 231138194 | 34 | 445038 | 1 | 1 |
| 2023-07-26 | 8-K | 8-K | 1.01,7.01,9.01 | 0001193125-23-194715 | 001-36407 | 231114534 | 34 | 199421 | 1 | 1 |
| 2023-06-30 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-179631 | 001-36407 | 231059740 | 34 | 180352 | 1 | 1 |
| 2023-05-23 | 8-K | 8-K | 5.07,9.01 | 0001193125-23-151845 | 001-36407 | 23949303 | 34 | 161290 | 1 | 1 |
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000068 | 5474 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000067 | 5466 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000066 | 9697 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000065 | 5491 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000064 | 9624 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000063 | 5498 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000062 | 5508 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000061 | 5499 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000060 | 9627 | ||||||
| 2023-05-19 | 4 | PRIMARY DOCUMENT | 0001735276-23-000059 | 9813 | ||||||
| 2023-05-04 | 10-Q | 10-Q | 0001178670-23-000011 | 001-36407 | 23886669 | 34 | 8083838 | 1 | 1 | |
| 2023-05-04 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 2.02,9.01 | 0001157523-23-000728 | 001-36407 | 23886645 | 34 | 536790 | 1 | 1 |
| 2023-04-28 | 4 | PRIMARY DOCUMENT | 0001735276-23-000048 | 15289 | ||||||
| 2023-04-28 | 4 | PRIMARY DOCUMENT | 0001735276-23-000047 | 15248 | ||||||
| 2023-04-28 | 4 | PRIMARY DOCUMENT | 0001735276-23-000046 | 14343 | ||||||
| 2023-04-28 | 4 | PRIMARY DOCUMENT | 0001735276-23-000045 | 15228 | ||||||
| 2023-04-28 | 4 | PRIMARY DOCUMENT | 0001735276-23-000044 | 27056 | ||||||
| 2023-04-28 | 144 | xsl144X01/primary_doc.xml | 0001973141-23-000011 | 001-36407 | 23863484 | 33 | 5051 | |||
| 2023-04-10 | 4 | PRIMARY DOCUMENT | 0001735276-23-000038 | 4777 | ||||||
| 2023-04-03 | ARS | ARS | 0001193125-23-089638 | 001-36407 | 23793291 | 34 | 9149257 | |||
| 2023-04-03 | DEFA14A | DEFA14A | 0001193125-23-089620 | 001-36407 | 23793230 | 34 | 134668 | |||
| 2023-04-03 | DEF 14A | DEF 14A | 0001193125-23-089611 | 001-36407 | 23793196 | 34 | 4561652 | 1 | 1 | |
| 2023-03-09 | 4 | PRIMARY DOCUMENT | 0001735276-23-000036 | 5333 | ||||||
| 2023-03-09 | 3 | PRIMARY DOCUMENT | 0001735276-23-000035 | 7239 | ||||||
| 2023-03-08 | 8-K | 8-K | 5.02 | 0001193125-23-064580 | 001-36407 | 23716547 | 34 | 146969 | 1 | 1 |
| 2023-03-07 | 4 | PRIMARY DOCUMENT | 0001735276-23-000033 | 14055 | ||||||
| 2023-03-01 | 4 | PRIMARY DOCUMENT | 0001735276-23-000031 | 12857 | ||||||
| 2023-03-01 | 4 | PRIMARY DOCUMENT | 0001735276-23-000030 | 12792 | ||||||
| 2023-03-01 | 4 | PRIMARY DOCUMENT | 0001735276-23-000029 | 12857 | ||||||
| 2023-03-01 | 4 | PRIMARY DOCUMENT | 0001735276-23-000028 | 12804 | ||||||
| 2023-03-01 | 4 | PRIMARY DOCUMENT | 0001735276-23-000027 | 12842 | ||||||
| 2023-03-01 | 4 | PRIMARY DOCUMENT | 0001735276-23-000026 | 12844 | ||||||
| 2023-02-27 | 4 | PRIMARY DOCUMENT | 0001735276-23-000019 | 10853 | ||||||
| 2023-02-27 | 4 | PRIMARY DOCUMENT | 0001735276-23-000018 | 11711 | ||||||
| 2023-02-27 | 4 | PRIMARY DOCUMENT | 0001735276-23-000017 | 10854 | ||||||
| 2023-02-27 | 4 | PRIMARY DOCUMENT | 0001735276-23-000016 | 10857 | ||||||
| 2023-02-27 | 4 | PRIMARY DOCUMENT | 0001735276-23-000015 | 11734 | ||||||
| 2023-02-23 | S-8 | S-8 | 0001193125-23-046503 | 333-269939 | 23659533 | 33 | 88128 | |||
| 2023-02-23 | 10-K | 10-K | 0001178670-23-000005 | 001-36407 | 23656033 | 34 | 16582177 | 1 | 1 | |
| 2023-02-23 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 2.02,9.01 | 0001157523-23-000344 | 001-36407 | 23656022 | 34 | 681216 | 1 | 1 |
| 2023-02-14 | 4 | PRIMARY DOCUMENT | 0001735276-23-000009 | 17050 | ||||||
| 2023-02-14 | CT ORDER | filename1.pdf | 20230214,20230214 | 9999999997-23-000606 | 001-36407 | 23626027 | 34 | 133820 | ||
| 2023-02-14 | SC 13G/A | alny13gadec22.txt | 0000080255-23-002573 | 005-79884 | 34 | 7205 | ||||
| 2023-02-13 | SC 13G/A | SEC SCHEDULE 13G | 0001422849-23-000032 | 005-79884 | 23617352 | 34 | 18391 | |||
| 2023-02-09 | SC 13G/A | SCHEDULE 13G/A | 0001104659-23-015258 | 005-79884 | 23602408 | 34 | 13132 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001402 | 005-79884 | 23601239 | 34 | 8408 | |||
| 2023-02-06 | SC 13G/A | SEC SCHEDULE 13G | 0000846087-23-000069 | 005-79884 | 23590016 | 34 | 33896 | |||
| 2023-02-03 | 4 | PRIMARY DOCUMENT | 0001735276-23-000007 | 14228 | ||||||
| 2023-02-03 | 4 | PRIMARY DOCUMENT | 0001735276-23-000006 | 23478 | ||||||
| 2023-01-31 | SC 13G/A | us02043q1076_013123.txt | 0001306550-23-005164 | 005-79884 | 23571844 | 34 | 13741 | |||
| 2023-01-19 | SC 13G/A | alnylam30122022.txt | 0001088875-23-000022 | 005-79884 | 23536625 | 34 | 11304 | |||
| 2023-01-09 | 4 | PRIMARY DOCUMENT | 0001735276-23-000003 | 5236 | ||||||
| 2023-01-09 | 3 | PRIMARY DOCUMENT | 0001735276-23-000002 | 7079 | ||||||
| 2023-01-09 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-23-004109 | 001-36407 | 23516498 | 34 | 182394 | 1 | 1 |
| 2023-01-06 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-23-003554 | 001-36407 | 23515271 | 34 | 180838 | 1 | 1 |
| 2022-12-07 | 4 | PRIMARY DOCUMENT | 0001735276-22-000078 | 15796 | ||||||
| 2022-11-23 | 4 | PRIMARY DOCUMENT | 0001735276-22-000076 | 12502 | ||||||
| 2022-10-27 | 10-Q | 10-Q | 0001178670-22-000026 | 001-36407 | 221334995 | 34 | 10339832 | 1 | 1 | |
| 2022-10-27 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 2.02,9.01 | 0001157523-22-001411 | 001-36407 | 221334980 | 34 | 652525 | 1 | 1 |
| 2022-09-16 | 8-K | 8-K | 1.01,1.02,2.03,3.02,9.01 | 0001193125-22-246487 | 001-36407 | 221248752 | 34 | 1254253 | 1 | 1 |
| 2022-09-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-243702 | 001-36407 | 221240807 | 34 | 201782 | 1 | 1 |
| 2022-09-09 | SC 13G | SEC SCHEDULE 13G | 0001422849-22-000166 | 005-79884 | 221235523 | 34 | 18352 | |||
| 2022-08-24 | 8-K | 8-K | 5.02 | 0001193125-22-228534 | 001-36407 | 221191712 | 34 | 146593 | 1 | 1 |
| 2022-08-24 | 4 | PRIMARY DOCUMENT | 0001735276-22-000074 | 5235 | ||||||
| 2022-08-24 | 3 | PRIMARY DOCUMENT | 0001735276-22-000073 | 8016 | ||||||
| 2022-08-17 | 4 | PRIMARY DOCUMENT | 0001735276-22-000069 | 20502 | ||||||
| 2022-08-05 | 4 | PRIMARY DOCUMENT | 0001735276-22-000067 | 21195 | ||||||
| 2022-08-05 | 4 | PRIMARY DOCUMENT | 0001735276-22-000066 | 15480 | ||||||
| 2022-08-05 | 4 | PRIMARY DOCUMENT | 0001735276-22-000065 | 16633 | ||||||
| 2022-08-05 | 4 | PRIMARY DOCUMENT | 0001735276-22-000064 | 15462 | ||||||
| 2022-08-05 | 4 | PRIMARY DOCUMENT | 0001735276-22-000063 | 15521 | ||||||
| 2022-07-28 | 10-Q | 10-Q | 0001178670-22-000020 | 001-36407 | 221112916 | 34 | 8818351 | 1 | 1 | |
| 2022-07-28 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 2.02,9.01 | 0001157523-22-000945 | 001-36407 | 221112891 | 34 | 623507 | 1 | 1 |
| 2022-07-07 | 4 | PRIMARY DOCUMENT | 0001735276-22-000057 | 4729 | ||||||
| 2022-06-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-173444 | 001-36407 | 221013429 | 34 | 188720 | 1 | 1 |
| 2022-05-23 | 8-K | 8-K | 5.07,9.01 | 0001193125-22-157503 | 001-36407 | 22952142 | 34 | 161897 | 1 | 1 |
| 2022-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-22-000055 | 5446 | ||||||
| 2022-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-22-000054 | 5483 | ||||||
| 2022-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-22-000053 | 5463 | ||||||
| 2022-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-22-000052 | 5425 | ||||||
| 2022-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-22-000051 | 5470 | ||||||
| 2022-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-22-000050 | 5480 | ||||||
| 2022-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-22-000049 | 5471 | ||||||
| 2022-05-20 | 4 | PRIMARY DOCUMENT | 0001735276-22-000048 | 5611 | ||||||
| 2022-04-28 | 10-Q | 10-Q | 0001178670-22-000016 | 001-36407 | 22862395 | 34 | 8428581 | 1 | 1 | |
| 2022-04-28 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | 2.02,9.01 | 0001157523-22-000494 | 001-36407 | 22862343 | 34 | 451170 | 1 | 1 |
| 2022-04-05 | DEFA14A | DEFA14A | 0001193125-22-096193 | 001-36407 | 22807152 | 34 | 962985 | |||
| 2022-04-05 | DEF 14A | DEF 14A | 0001193125-22-096188 | 001-36407 | 22807117 | 34 | 2591193 | |||
| 2022-04-05 | 8-K | 8-K | 5.02,9.01 | 0001193125-22-096176 | 001-36407 | 22807030 | 34 | 168433 | 1 | 1 |
| 2022-04-05 | 4 | PRIMARY DOCUMENT | 0001735276-22-000039 | 21861 | ||||||
| 2022-04-04 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-094409 | 001-36407 | 22800380 | 34 | 170629 | 1 | 1 |
| 2022-03-17 | 8-K | 8-K | 8.01 | 0001193125-22-077831 | 001-36407 | 22746746 | 34 | 143485 | 1 | 1 |
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000037 | 5872 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000036 | 5848 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000035 | 5815 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000034 | 5791 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000033 | 5850 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000032 | 5553 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000031 | 5562 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000030 | 5545 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000029 | 5552 | ||||||
| 2022-02-25 | 4 | PRIMARY DOCUMENT | 0001735276-22-000028 | 5528 | ||||||
| 2022-02-14 | SC 13G | alny13gdec21.txt | 0000080255-22-002028 | 005-79884 | 34 | 6973 |
One latest value per concept from companyfacts (456 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 133.94M | 2026-10-23 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| dei | EntityNumberOfEmployees | Entity Number of Employees | Employee | 115 | 2012-01-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 42.63B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 2.99B | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001628280-26-023923 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 19.82M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001628280-26-023923 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 6.58M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001628280-26-023923 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 124.75 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001628280-26-023923 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 77.43M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001628280-26-023923 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 14.87M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001628280-26-023923 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 305.96 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001628280-26-023923 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 135.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AccountsReceivableNet | Accounts Receivable, after Allowance for Credit Loss | USD | 102.74M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001178670-25-000026 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 1.08B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AccruedIncomeTaxesCurrent | Accrued Income Taxes, Current | USD | 0 | 2010-12-31 | 2010 | FY | 10-K | 2011-02-18 | 0000950123-11-015737 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 1.24B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 34.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 322.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax | USD | 15.70M | 2012-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -44.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 7.81B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 58,000 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-02 | 0001564590-19-015366 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 80.22M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | USD | 120,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 36.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 235.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 879,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | Assets | Assets | USD | 7.99B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 5.11B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 2.05B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 3.46M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001628280-25-047345 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 94,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001628280-25-047345 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 1.26B | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001628280-25-047345 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 5,000 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 2.07M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 303.26M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001193125-13-204676 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 648,000 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 648,000 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 1.05B | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-02 | 0001564590-19-015366 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 1.05B | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-02 | 0001564590-19-015366 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 1.26B | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001628280-25-047345 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 1.83B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 13.92M | 2017-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecurities | Available-for-sale Securities, Equity Securities | USD | 38.70M | 2012-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecuritiesCurrent | Available-for-sale Securities, Equity Securities, Current | USD | 9.00M | 2016-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 | |
| us-gaap | AvailableForSaleSecuritiesEquitySecuritiesNoncurrent | Available-for-sale Securities, Equity Securities, Noncurrent | USD | 45.45M | 2013-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | AvailableForSaleSecuritiesFairValueDisclosure | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | USD | 303.02M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001193125-13-204676 | |
| us-gaap | AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments | USD | -1.89M | 2017-01-01 | 2017-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028070 |
| us-gaap | AvailableforsaleSecuritiesGrossUnrealizedGain | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) | USD | 27,000 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001193125-13-204676 | |
| us-gaap | AvailableForSaleSecuritiesGrossUnrealizedLosses1 | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | USD | 260,000 | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001193125-13-204676 | |
| us-gaap | AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss | Available-for-sale Securities, Income Tax Expense on Change in Unrealized Holding Gain (Loss) (Deprecated 2018-01-31) | USD | -2.69M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | AvailableForSaleSecuritiesNoncurrent | Available-for-sale Securities, Noncurrent | USD | 164.82M | 2013-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001193125-13-204676 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 29.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | CapitalizedContractCostNet | Capitalized Contract Cost, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 1.75B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 44.21M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 451.74M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 1.76B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 1.49B | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001628280-25-047345 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -248.96M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 97.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 80 | 2005-07-13 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 0.001 | 2005-07-13 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 250.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 133.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 133.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CommonStockValueOutstanding | Common Stock, Value, Outstanding | USD | 1.26M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001178670-24-000008 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | 2.51B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 260.98M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 4.59M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 525,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ContractualObligationDueInFifthYear | Contractual Obligation, to be Paid, Year Five | USD | 525,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ContractualObligationDueInFourthYear | Contractual Obligation, to be Paid, Year Four | USD | 545,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 1.45M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 795,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ContractualObligationDueInThirdYear | Contractual Obligation, to be Paid, Year Three | USD | 745,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 55.48M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001178670-25-000026 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 11.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001178670-25-000026 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 4.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ConvertibleDebtCurrent | Convertible Debt, Current | USD | 361.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | ConvertibleDebtNoncurrent | Convertible Debt, Noncurrent | USD | 651.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 867.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 3.07B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 68.21M | 2018-01-01 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | CumulativeEffectOnRetainedEarningsNetOfTax1 | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) | USD | 68.21M | 2018-01-01 | 2018-03-31 | 2019 | Q3 | 10-Q | 2019-10-31 | 0001178670-19-000005 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 1.60M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001178670-25-000026 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 9.67M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 11.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 1.93M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.1 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001178670-24-000008 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | -2.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | DeferredIncomeTaxAssetsNet | Deferred Income Tax Assets, Net | USD | 2.01B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 10.74M | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -1.88B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | DeferredRentCreditCurrent | Deferred Rent Credit, Current | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 43.53M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 35.85M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 7.68M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 1.22M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsDerivativeInstruments | Deferred Tax Assets, Derivative Instruments | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsEquityMethodInvestments | Deferred Tax Assets, Equity Method Investments | USD | 1.62M | 2016-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 593.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 2.92B | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 12.14M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 125.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsNetCurrent | Deferred Tax Assets, Net of Valuation Allowance, Current | USD | 0 | 2010-12-31 | 2010 | FY | 10-K | 2011-02-18 | 0000950123-11-015737 | |
| us-gaap | DeferredTaxAssetsNetNoncurrent | Deferred Tax Assets, Net of Valuation Allowance, Noncurrent | USD | 31.67M | 2014-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-462538 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 987.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 90.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 2.47M | 2017-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 788,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-462538 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax | Deferred Tax Assets, Tax Credit Carryforwards, Alternative Minimum Tax | USD | 394,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsForeign | Deferred Tax Assets, Tax Credit Carryforwards, Foreign | USD | 3.20M | 2016-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsOther | Deferred Tax Assets, Tax Credit Carryforwards, Other | USD | 788,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 452.26M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 69.98M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 2.73B | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxLiabilitiesCurrent | Deferred Tax Liabilities, Net, Current | USD | 31.67M | 2014-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-462538 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 7,000 | 2013-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | DeferredTaxLiabilitiesInvestments | Deferred Tax Liabilities, Investments | USD | 6.47M | 2012-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 41.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxLiabilitiesOtherComprehensiveIncome | Deferred Tax Liabilities, Other Comprehensive Income | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 17.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | Depreciation | Depreciation | USD | 54.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | DepreciationAmortizationAndAccretionNet | Depreciation, Amortization and Accretion, Net | USD | 41.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 3.18M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 486.92M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 19.02 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.71 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-04-29 | 0001178670-21-000017 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | 18.42 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0.029 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.029 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.027 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiAmount | EffectiveIncomeTaxRateReconciliationGiltiAmount | USD | 86.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationGiltiPercent | EffectiveIncomeTaxRateReconciliationGiltiPercent | pure | 0.267 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.281 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.013 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.007 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0.059 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.042 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsInvestment | Effective Income Tax Rate Reconciliation, Tax Credit, Investment, Percent | pure | -0.075 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.086 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | -29,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -10.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | EffectOnFutureEarningsOffsetAmount | Effect on Future Earnings, Offset Amount | USD | 20.00M | 2012-01-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 257.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount | Share-based Payment Arrangement, Amount Capitalized | USD | 3.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 31.80M | 2013-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 | |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.12 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | -2.75M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationAssets | Equity Method Investment, Summarized Financial Information, Assets (Deprecated 2020-01-31) | USD | 42.88M | 2011-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationCostOfSales | Equity Method Investment, Summarized Financial Information, Cost of Sales (Deprecated 2020-01-31) | USD | 17.73M | 2012-01-01 | 2012-09-30 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets | Equity Method Investment, Summarized Financial Information, Current Assets (Deprecated 2020-01-31) | USD | 38.67M | 2011-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities | Equity Method Investment, Summarized Financial Information, Current Liabilities (Deprecated 2020-01-31) | USD | 12.85M | 2011-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationEquity | Equity Method Investment Summarized Financial Information, Equity (Deprecated 2020-01-31) | USD | -6.43M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationIncomeLossFromContinuingOperationsBeforeExtraordinaryItems | Equity Method Investment, Summarized Financial Information, Income (Loss) from Continuing Operations (Deprecated 2020-01-31) | USD | -8.27M | 2012-01-01 | 2012-09-30 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) | USD | -10.53M | 2012-01-01 | 2012-09-30 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities | Equity Method Investment, Summarized Financial Information, Noncurrent Liabilities (Deprecated 2020-01-31) | USD | 28.83M | 2011-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 | |
| us-gaap | EquityMethodInvestmentSummarizedFinancialInformationRevenue | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) | USD | 9.46M | 2012-01-01 | 2012-09-30 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | EquitySecuritiesFvNiGainLoss | Equity Securities, FV-NI, Gain (Loss) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | EquitySecuritiesFvNiUnrealizedGainLoss | Equity Securities, FV-NI, Unrealized Gain (Loss) | USD | 69.64M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001178670-20-000015 |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationOperatingActivities | Excess Tax Benefit from Share-based Compensation, Operating Activities | USD | -120,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001178670-20-000015 | |
| us-gaap | FairValueEquityLevel2ToLevel1TransfersAmount | Fair Value, Equity, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-09 | 0001193125-14-192579 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-10-31 | 0001178670-24-000053 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net | USD | 0 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-10-31 | 0001178670-24-000053 |
| us-gaap | FederalIncomeTaxExpenseBenefitContinuingOperations | Federal Income Tax Expense (Benefit), Continuing Operations | USD | -40.21M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-15 | 0001564590-17-001649 |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 145,000 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 | |
| us-gaap | ForeignIncomeTaxExpenseBenefitContinuingOperations | Foreign Income Tax Expense (Benefit), Continuing Operations | USD | -34,000 | 2013-01-01 | 2013-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-462538 |
| us-gaap | FurnitureAndFixturesGross | Furniture and Fixtures, Gross | USD | 7.24M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | GainContingencyPatentsFoundNotInfringedUponNumber | Gain Contingency, Patents Found Not Infringed upon, Number | patent | 2 | 2023-01-01 | 2023-12-31 | 2025 | Q2 | 10-Q | 2025-07-31 | 0001178670-25-000090 |
| us-gaap | GainContingencyUnrecordedAmount | Gain Contingency, Unrecorded Amount | USD | 8.00M | 2015-10-14 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 | |
| us-gaap | GainLossOnSaleOfPreviouslyUnissuedStockBySubsidiaryOrEquityInvesteeNonoperatingIncome | Gain (Loss) on Sale of Previously Unissued Stock by Subsidiary or Equity Investee, Nonoperating Income | USD | 16.08M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 157.13M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001564590-18-018696 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 1.56M | 2008-01-01 | 2008-12-31 | 2010 | FY | 10-K | 2011-02-18 | 0000950123-11-015737 |
| us-gaap | IncentiveFromLessor | Incentive from Lessor | USD | 2.10M | 2016-12-31 | 2016 | FY | 10-K | 2017-02-15 | 0001564590-17-001649 | |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | 18.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 695.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 304.85M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments | Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | USD | -855.60M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-11 | 0001178670-21-000010 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | -4.52M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 2.57M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 29.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 0 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-13 | 0001193125-12-053552 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -1.84B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | IncomeTaxExpenseBenefitIntraperiodTaxAllocation | Income Tax Expense (Benefit), Intraperiod Tax Allocation | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 9.37M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | 67.86M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 2.15M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | -90.69M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -4.11M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -2.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 18.99M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 27.65M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -3.72M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-31 | 0001178670-19-000005 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -18.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 313.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | -5.52M | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 6.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -2.89M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001564590-18-018696 |
| us-gaap | IncreaseDecreaseInIncomeTaxesReceivable | Increase (Decrease) in Income Taxes Receivable | USD | -10.67M | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 2.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -37.84M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-10-31 | 0001178670-24-000053 |
| us-gaap | IncreaseDecreaseInOtherAccruedLiabilities | Increase (Decrease) in Other Accrued Liabilities | USD | 36.35M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-31 | 0001178670-19-000005 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 102.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | IncreaseDecreaseInReceivables | Increase (Decrease) in Receivables | USD | -31.04M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001564590-18-018696 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 288,000 | 2015-01-01 | 2015-03-31 | 2016 | Q1 | 10-Q | 2016-05-04 | 0001193125-16-577773 |
| us-gaap | IncreaseDecreaseInRestrictedCashAndInvestments | Increase (Decrease) in Restricted Cash and Investments | USD | 150.00M | 2016-01-01 | 2016-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 2.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | InducedConversionOfConvertibleDebtExpense | Induced Conversion of Convertible Debt Expense | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | InterestExpense | Interest Expense | USD | 35.25M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-02 | 0001178670-24-000023 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 235.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | InterestOnConvertibleDebtNetOfTax | Interest on Convertible Debt, Net of Tax | USD | 3.52M | 2023-07-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001178670-23-000023 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 2.43M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 195.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 40.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 105.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 11.30M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 18.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 58.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 85.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 5.48M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-06 | 0001178670-20-000007 |
| us-gaap | InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures | Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | USD | 564,000 | 2011-12-31 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 | |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 3.20M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | Land | Land | USD | 9.08M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 74.37M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 65.93M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 366.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 136.38M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 48.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 41.78M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 42.99M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 44.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 52.75M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 8.22M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-31 | 0001178670-19-000005 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 95.67M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | Liabilities | Liabilities | USD | 4.39B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 7.99B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 2.06B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | LicenseAndServicesRevenue | License and Services Revenue (Deprecated 2018-01-31) | USD | 21.90M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 |
| us-gaap | LongTermDebt | Long-term Debt | USD | 677.72M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-07-28 | 0001178670-22-000020 | |
| us-gaap | LossContingencyAccrualAtCarryingValue | Loss Contingency Accrual | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | MachineryAndEquipmentGross | Machinery and Equipment, Gross | USD | 43.43M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | -595,000 | 2011-01-01 | 2011-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | 511,000 | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-13 | 0001193125-12-053552 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 70.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 41.52M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -700.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -134.81M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 738.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -155.66M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | 2.54B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | NetIncomeLossAttributableToParentDiluted | Net Income (Loss) Attributable to Parent, Diluted | USD | 2.54B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | NetRentableArea | Net Rentable Area | sqft | 129,000 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 | |
| us-gaap | NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 | Noncash or Part Noncash Acquisition, Value of Assets Acquired | USD | 195.77M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-15 | 0001564590-17-001649 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -150.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OciBeforeReclassificationsNetOfTaxAttributableToParent | OCI, before Reclassifications, Net of Tax, Attributable to Parent | USD | -19.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 391.56M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001564590-18-018696 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | 845.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 49.82M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 61.60M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001178670-24-000008 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 270.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 46.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 203.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 50.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 177.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 562.01M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 32.23M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals | Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals | USD | 10.00M | 2012-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 35.27M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 34.83M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 34.41M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 34.83M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 390.45M | 2018-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 52.40M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.08 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 25.57M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 60.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent | USD | -267,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax (Deprecated 2012-01-31) | USD | -29,000 | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-02-13 | 0001193125-12-053552 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) | USD | -29,000 | 2010-01-01 | 2010-12-31 | 2011 | FY | 10-K | 2012-02-13 | 0001193125-12-053552 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | USD | -5.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | USD | -4.08M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-01 | 0001178670-25-000052 |
| us-gaap | OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax | USD | 8.35M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001178670-23-000023 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -29,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -3.00M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-01 | 0001178670-25-000052 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -24.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax | Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax | USD | -55,000 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-01 | 0001178670-25-000052 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -19.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | USD | -10.60M | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 10.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -521,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-07 | 0001193125-15-282067 |
| us-gaap | OtherNoncashIncomeTaxExpense | Other Noncash Income Tax Expense | USD | -216,000 | 2010-01-01 | 2010-06-30 | 2011 | Q2 | 10-Q | 2011-08-03 | 0000950123-11-071950 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -579,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OtherOperatingActivitiesCashFlowStatement | Other Operating Activities, Cash Flow Statement | USD | 7.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | OtherPostretirementBenefitsPayments | Payment for Other Postretirement Benefits | USD | -96,000 | 2012-01-01 | 2012-03-31 | 2012 | Q1 | 10-Q | 2012-05-03 | 0001193125-12-208797 |
| us-gaap | OtherRestructuringCosts | Other Restructuring Costs | USD | 3.90M | 2012-01-01 | 2012-03-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 |
| us-gaap | OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net | USD | 595,000 | 2011-01-01 | 2011-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | PaymentsForCapitalImprovements | Payments for Capital Improvements | USD | 9.06M | 2016-01-01 | 2016-03-31 | 2017 | Q1 | 10-Q | 2017-05-05 | 0001564590-17-008948 |
| us-gaap | PaymentsForPreviousAcquisition | Payments for Previous Acquisition | USD | 44.30M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001178670-23-000005 |
| us-gaap | PaymentsForProceedsFromDerivativeInstrumentFinancingActivities | Payments for (Proceeds from) Derivative Instrument, Financing Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | 27.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | PaymentsForProceedsFromTenantAllowance | Payments for (Proceeds from) Tenant Allowance | USD | -5.55M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-11 | 0001178670-21-000010 |
| us-gaap | PaymentsForRepurchaseOfCommonStockForEmployeeTaxWithholdingObligations | Payments for Repurchase of Common Stock for Employee Tax Withholding Obligations (Deprecated 2013-01-31) | USD | 328,000 | 2012-01-01 | 2012-03-31 | 2013 | Q1 | 10-Q | 2013-05-07 | 0001193125-13-204676 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 5.60M | 2019-01-01 | 2019-01-31 | 2021 | FY | 10-K | 2022-02-10 | 0001178670-22-000013 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 84,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-06 | 0001564590-19-029367 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 364.31M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 1.35B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 25.00M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-15 | 0001564590-17-001649 |
| us-gaap | PaymentsToAcquireInterestInJointVenture | Payments to Acquire Interest in Joint Venture | USD | 10.00M | 2009-01-01 | 2009-12-31 | 2011 | FY | 10-K | 2012-02-13 | 0001193125-12-053552 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 126.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | PaymentsToAcquireRestrictedInvestments | Payments to Acquire Restricted Investments | USD | 22.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | PensionAndOtherPostretirementBenefitExpense | Pension and Other Postretirement Benefits Cost (Reversal of Cost) | USD | 3.27M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-10-31 | 0001178670-19-000005 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 5.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | PreferredStockValueOutstanding | Preferred Stock, Value, Outstanding | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-15 | 0001178670-24-000008 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 334.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ProceedsFromDerivativeInstrumentFinancingActivities | Proceeds from Derivative Instrument, Financing Activities | USD | 1.77M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-01 | 0001178670-24-000041 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-10 | 0001178670-22-000013 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-07-28 | 0001178670-22-000020 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001178670-23-000005 |
| us-gaap | ProceedsFromIssuanceOfSecuredDebt | Proceeds from Issuance of Secured Debt | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001178670-23-000005 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 62.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 993,000 | 2010-01-01 | 2010-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-10-27 | 0001178670-22-000026 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | -16,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ProceedsFromRepaymentsOfSecuredDebt | Proceeds from (Repayments of) Secured Debt | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001178670-25-000026 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 244.88M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-04 | 0001564590-18-011031 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 753.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ProceedsFromSaleOfRestrictedInvestments | Proceeds from Sale of Restricted Investments | USD | 68.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -1.13B | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001178670-23-000005 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 835.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 614.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | PropertyPlantAndEquipmentOther | Property, Plant and Equipment, Other, Gross | USD | 28.56M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 150.20M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-462538 | |
| us-gaap | PurchaseObligationDueInNextTwelveMonths | Purchase Obligation, to be Paid, Year One | USD | 87.50M | 2015-12-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-462538 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 2.96M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-02 | 0001564590-18-018696 | |
| us-gaap | ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax | USD | -3.97M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001178670-23-000023 |
| us-gaap | ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent | Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent | USD | 4.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-02 | 0001178670-23-000023 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001178670-20-000019 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 6.76M | 2008-01-01 | 2008-12-31 | 2010 | FY | 10-K | 2011-02-18 | 0000950123-11-015737 |
| us-gaap | RepaymentsOfSecuredDebt | Repayments of Secured Debt | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-02-11 | 0001178670-21-000010 |
| us-gaap | ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff | Research and Development Asset Acquired Other than Through Business Combination, Written-off | USD | 220.77M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-15 | 0001564590-17-001649 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 1.19B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 2.55M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001628280-25-047345 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 2.14M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028070 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 1.56M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 1.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | RestrictedInvestmentsNoncurrent | Restricted Investments, Noncurrent | USD | 22.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | RestrictedStockExpense | Restricted Stock or Unit Expense | USD | 3.40M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.33 | 2012-01-01 | 2012-01-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 3.90M | 2012-01-01 | 2012-03-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 356,000 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 | |
| us-gaap | RestructuringReserveAccrualAdjustment | Restructuring Reserve, Accrual Adjustment (Deprecated 2016-01-31) | USD | 0 | 2012-07-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 |
| us-gaap | RestructuringReserveSettledWithCash | Restructuring Reserve, Settled With Cash (Deprecated 2013-01-31) | USD | 767,000 | 2012-07-01 | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -4.16B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 3.92B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | Revenues | Revenues | USD | 1.04B | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001178670-23-000005 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 457,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | SaleOfStockConsiderationReceivedPerTransaction | Sale of Stock, Consideration Received Per Transaction | USD | 10.00M | 2009-03-01 | 2009-03-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | SalesRevenueNet | Revenue, Net (Deprecated 2018-01-31) | USD | 20.90M | 2011-01-01 | 2011-03-31 | 2011 | Q1 | 10-Q | 2011-05-05 | 0000950123-11-045184 |
| us-gaap | SecuredLongTermDebt | Secured Long-term Debt, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001178670-23-000005 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 1.01B | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 235.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1 | Share-based Payment Arrangement, Expensed and Capitalized, Amount | USD | 239.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | USD/shares | 0 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 29,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 68.28 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 30,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 68.02 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 499,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 10.59 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.57 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.66 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.63 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.026 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.014 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-13 | 0001178670-20-000004 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 15.56M | 2017-12-31 | 2017 | FY | 10-K | 2018-02-15 | 0001564590-18-002152 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 357.89M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 4.74M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 21.44 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 126.50M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 85,000 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 1.35M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 8.68 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 478.51M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 7.53M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 33.46 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 12.82 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 470.15M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 7.29M | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 32.53 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 14.83 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 35.32 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 75.77 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | ShareBasedGoodsAndNonemployeeServicesTransactionExpense | Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) | USD | 1.00M | 2012-01-01 | 2012-12-31 | 2012 | FY | 10-K | 2013-02-19 | 0001193125-13-065475 |
| us-gaap | SharePrice | Share Price | USD/shares | 478.63 | 2025-09-09 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001628280-25-047345 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 77.5 | 2019-01-31 | 2021 | FY | 10-K | 2022-02-10 | 0001178670-22-000013 | |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensationGross | Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture | USD | 16.68M | 2011-01-01 | 2011-12-31 | 2011 | FY | 10-K | 2012-02-13 | 0001193125-12-053552 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 3.60B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 158.23M | 2010-12-31 | 2010 | FY | 10-K | 2011-02-18 | 0000950123-11-015737 | |
| us-gaap | StockholdersEquityPeriodIncreaseDecrease | Stockholders' Equity, Period Increase (Decrease) | USD | -288.30M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-07 | 0001564590-18-028070 |
| us-gaap | StockIssued1 | Stock Issued | USD | 51.45M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-15 | 0001564590-17-001649 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 5.00M | 2019-01-01 | 2019-01-31 | 2021 | FY | 10-K | 2022-02-10 | 0001178670-22-000013 |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | shares | 508,928 | 2012-01-01 | 2012-01-31 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 1.98M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeBenefitPlan | Stock Issued During Period, Value, Employee Benefit Plan | USD | 99.50M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001178670-23-000005 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 99.50M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-02-10 | 0001178670-22-000013 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 784,000 | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-02 | 0001564590-19-015366 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 195.77M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-15 | 0001564590-17-001649 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 2.30M | 2011-05-01 | 2011-05-31 | 2015 | FY | 10-K | 2016-02-12 | 0001193125-16-462538 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | -519,000 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-02-13 | 0001193125-15-050223 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensationGross | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | USD | 0 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 14.70M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | TaxAdjustmentsSettlementsAndUnusualProvisions | Tax Adjustments, Settlements, and Unusual Provisions | USD | 20.68M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-02-15 | 0001564590-17-001649 |
| us-gaap | UndistributedEarningsOfForeignSubsidiaries | Undistributed Earnings of Foreign Subsidiaries | USD | 86.20M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-13 | 0001178670-25-000026 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 77.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 128,000 | 2012-01-01 | 2012-12-31 | 2013 | FY | 10-K | 2014-02-20 | 0001193125-14-060913 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 1.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-10 | 0001178670-22-000013 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 10.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 9.47M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-14 | 0001564590-19-003022 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 1.95B | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | ValuationAllowancesAndReservesBalance | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount | USD | 556.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 | |
| us-gaap | VariableInterestEntityEntityMaximumLossExposureAmount | Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount | USD | 5.60M | 2012-09-30 | 2012 | Q3 | 10-Q | 2012-11-05 | 0001193125-12-452123 | |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 24.55M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-12 | 0001628280-26-007497 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 138.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 117.08M | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-04-29 | 0001178670-21-000017 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 133.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-10-29 | 0001178670-26-000076 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) | shares | 42.38M | 2011-06-30 | 2011 | Q2 | 10-Q | 2011-08-03 | 0000950123-11-071950 |